Abstract:An arecoline (ARC)-induced oral mucosal injury rat model was established to determine the protective effects and mechanism of action of astaxanthin (AST) on oral epithelial injury. Pathological morphology and changes in human early growth response factor 1 (EGR1) were investigated in rat oral mucosal tissue. The ARC-induced changes in tight junction related proteins (ZO-1 and occludin), mitochondrial morphology, mitochondrial membrane potential (MMP), mitochondrial reactive oxygen species (mtROS), and EGR1 in human oral keratinocyte (HOK) cells were measured. The binding of AST and EGR1 was predicted using molecular docking. Based on the pathological sections of oral mucosal tissues, the AST intervention groups showed improvements in symptoms such as thinning oral mucosal epithelium and shortened epithelial rete pegs compared to the model group. The relative submucosal collagen and collagen I areas were substantially reduced by 9.84% and 23.01%, respectively. The in vitro experiments indicated that AST improved the abnormal localization of ZO-1 and occludin proteins in ARC-induced HOK cells; the abnormal mitochondrial morphology, decreased level of MMP, and excessive generation of mtROS were also ameliorated. In addition, AST inhibited the expression level of EGR1 in ARC-induced HOK cells, which was down regulated by 24.53% at the cellular level. The molecular docking results indicated that the docking binding energy between AST and EGR1 was −6.869 7 kcal/mol, and involved two hydrogen bonding interactions. In summary, AST shows promise in mitigating ARC-induced oral mucosal injury by regulating EGR1 and mitochondrial function and is expected to be further developed as a functional food for the protection of the oral mucosa.